4.4 Review

Lessons Learned in Managing Patients with Colorectal Cancer During the COVID-19 Pandemic

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Impact of the COVID-19 pandemic on UK endoscopic activity and cancer detection: a National Endoscopy Database Analysis

Matthew D. Rutter et al.

Summary: The study found that the COVID-19 pandemic had a significant impact on endoscopic services and endoscopic cancer diagnosis. Endoscopic activity decreased to 12% of pre-COVID levels, leading to a gradual decrease in the number of cancers detected. Urgent efforts are needed to restore endoscopy capacity to prevent a potential cancer healthcare crisis.
Article Oncology

The COVID-19 Pandemic: Identifying Adaptive Solutions for Colorectal Cancer Screening in Underserved Communities

Jesse N. Nodora et al.

Summary: The COVID-19 pandemic has halted preventive care measures including CRC screening, which poses health risks for underserved populations. To address this, the article suggests investing in community health centers and supporting telehealth solutions, as well as implementing mailed fecal immunochemical test programs and advocating for community gastroenterologists to provide colonoscopies for CHC patients.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

Article Oncology

Cancer Statistics, 2021

Rebecca L. Siegel et al.

Summary: Every year, the American Cancer Society projects the numbers of new cancer cases and deaths in the United States, with the latest data showing a significant decline in lung cancer mortality, while prostate cancer mortality has plateaued and breast and colorectal cancer mortality have slowed. Improvements in treatment have accelerated progress against lung cancer, leading to a record drop in overall cancer mortality.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Oncology

Mortality in hospitalized patients with cancer and coronavirus disease 2019: A systematic review and meta-analysis of cohort studies

Aakash Desai et al.

Summary: The analysis of 2922 cancer patients with COVID-19 from primarily inpatient studies showed a 30-day mortality rate of 30%, while the overall rate was 15% among 624 patients from studies including both inpatient and outpatient populations. Factors such as male sex, older age, cancer subtype, and recent active cancer therapy partially explained the heterogeneity in mortality reporting, with male sex and an interaction between patient age and recent therapy accounting for most of the variance in mortality rates between studies.

CANCER (2021)

Article Oncology

The mortality rate of COVID-19 was high in cancer patients: a retrospective single-center study

Gulcin Sahingoz Erdal et al.

Summary: The study found that cancer patients with COVID-19 are more at risk and have a significantly higher mortality rate compared to non-cancer patients. Factors such as receiving chemotherapy, lymphopenia, and elevated troponin I are associated with disease severity and mortality.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Are colorectal cancer patients at risk for COVID-19 infection during the postoperative period? The Covid-GRECCAR study

Jean-Jacques Tuech et al.

Summary: This French, multicenter cohort study followed colorectal cancer patients who underwent surgery between January 1 and March 31, 2020, at 19 hospitals until June 15, 2020. The results showed a low infection rate of 1.3% and no deaths related to COVID-19 in this group of patients.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2021)

Article Medicine, General & Internal

Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial

Robert L. Gottlieb et al.

Summary: The study showed that treatment with bamlanivimab and etesevimab was significantly associated with a reduction in SARS-CoV-2 viral load at day 11 in nonhospitalized patients with mild to moderate COVID-19, compared to placebo. However, bamlanivimab monotherapy did not show a significant reduction in viral load. Ongoing clinical trials will focus on assessing the clinical benefits of antispike neutralizing antibodies in COVID-19 patients.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Editorial Material Medicine, General & Internal

Racial and Ethnic Health Disparities Related to COVID-19

Leo Lopez et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Meeting Abstract Oncology

Quantifying the impact of the COVID-19 pandemic on gastrointestinal cancer care delivery.

Nicholas Perkons et al.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Medicine, General & Internal

Interim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine

J. Sadoff et al.

Summary: The study conducted a multicenter, placebo-controlled, phase 1-2a trial, with participants randomly assigned to receive the Ad26.COV2.S vaccine. The results showed that the safety and immunogenicity profiles of the vaccine support further development.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

A. C. Kalil et al.

Summary: Combination treatment with baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

Peter Chen et al.

Summary: LY-CoV555, a neutralizing antibody, showed promising results in reducing viral load, improving symptoms, and lowering the risk of hospitalization among patients with mild or moderate Covid-19. While one of the doses appeared to accelerate the decline in viral load, others did not show significant effects by day 11.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Surgery

Reduced duration of stay after elective colorectal surgery during the peak phase of COVID-19 pandemic: A positive effect of infection risk awareness?

Antonino Spinelli et al.

Summary: Despite the shutdown of elective surgery in most settings during the COVID-19 pandemic, some referral centers served as surgery hubs for major colorectal surgeries. The short-term outcomes of major colorectal surgeries during the pandemic were comparable in terms of complications and readmission rate, while a significantly shorter duration of stay was observed in patients undergoing surgery during the pandemic. The pandemic also revealed the positive impact of patients' commitment to reducing duration of stay and promoting compliance to enhanced recovery protocol.

SURGERY (2021)

Article Multidisciplinary Sciences

COVID-19 mortality in cancer patients: a report from a tertiary cancer centre in India

Anurag Mehta et al.

Summary: This study provides insights into the Case Fatality Rate, clinical associations, and risk factors for mortality in cancer patients with COVID-19 in India. It shows that the presence of comorbidities, severity of disease presentation, and pre-existing conditions like diabetes and cardiovascular diseases are significantly linked to COVID-19 related death in this cohort. Additionally, recent anticancer treatments do not appear to impact mortality rates.

PEERJ (2021)

Article Oncology

Immunological alternation in COVID-19 patients with cancer and its implications on mortality

Guangyao Cai et al.

Summary: Patients with cancer are more vulnerable to COVID-19 and have a higher mortality rate. Dysregulated immune responses in cancer patients may contribute to their poorer prognosis compared to noncancerous patients.

ONCOIMMUNOLOGY (2021)

Article Oncology

Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection

QuanQiu Wang et al.

Summary: This case-control study found that patients with recent cancer diagnosis were at significantly increased risk for COVID-19 infection and its adverse outcomes, with the strongest association for leukemia, non-Hodgkin lymphoma, and lung cancer. African American cancer patients had a higher risk of COVID-19 infection compared to White patients, highlighting the need for better protection and monitoring strategies.

JAMA ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study

Eva J. A. Morris et al.

Summary: The study found that the COVID-19 pandemic has led to a decrease in the detection and management of colorectal cancer in England. By October 2020, care pathway targets had returned to 2019 levels, albeit with modifications to usual practice and smaller volumes of patients. Urgent action is needed to address the growing burden of undetected and untreated colorectal cancer in England as the pressure grows in the NHS due to the second wave of COVID-19.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Medicine, General & Internal

SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

Michael A. Johansson et al.

Summary: The study suggests that more than half of COVID-19 transmission may come from asymptomatic individuals, highlighting the importance of measures beyond identifying and isolating symptomatic cases in controlling the spread of the virus.

JAMA NETWORK OPEN (2021)

Article Oncology

The impact of COVID-19 on systemic anticancer treatment delivery in Scotland

Mark A. Baxter et al.

Summary: The impact of the COVID-19 pandemic on systemic anticancer therapy delivery (SACT) has led to a rapid initial reduction in patient attendance, with subsequent recovery in NHS Scotland. Regional variations in the magnitude of impact were observed, but all regions showed similar rates of recovery. The coordinated national approach and support structures have limited the disadvantage to cancer patients during this time.

BRITISH JOURNAL OF CANCER (2021)

Article Infectious Diseases

Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study

Michael Marks et al.

Summary: The viral load of index cases is a key driver of SARS-CoV-2 transmission, while the viral load of contacts at baseline is strongly associated with the risk of developing symptomatic COVID-19 and shortening the incubation period in a dose-dependent manner.

LANCET INFECTIOUS DISEASES (2021)

Letter Biochemistry & Molecular Biology

COVID-19 vaccination: the VOICE for patients with cancer

Astrid A. M. van der Veldt et al.

NATURE MEDICINE (2021)

Review Oncology

Differences in mortality of cancer patients with COVID-19 in a Brazilian cancer center

Gisele Aparecida Fernandes et al.

Summary: A study conducted at a cancer center in Brazil analyzed COVID-19 mortality in cancer patients and found that individuals over 60 years of age, as well as those with lung and hematological cancers, were more likely to die from COVID-19. The findings highlight the importance of individualized management strategies for cancer patients to reduce the risk of death from COVID-19.

SEMINARS IN ONCOLOGY (2021)

Review Oncology

Safety and Efficacy of 7 Days on/7 Days off Versus 14 Days on/7 Days off Schedules of Capecitabine in Patients with Metastatic Colorectal Cancer: A Retrospective Review

Evan Bryson et al.

Summary: The study showed that the 7/7 treatment schedule of capecitabine for metastatic colorectal cancer patients resulted in significantly fewer dose reductions and treatment delays compared to the 14/7 schedule. Despite no difference in efficacy outcomes, prospective studies are needed to confirm these findings.

CLINICAL COLORECTAL CANCER (2021)

Review Medicine, General & Internal

Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement

Karina W. Davidson et al.

Summary: Colorectal cancer is a significant cause of cancer-related deaths, with high incidence in adults aged 65 to 74. Screening is recommended for adults aged 50 to 75 with substantial net benefit, for those aged 45 to 49 with moderate net benefit, and selective screening is advised for adults aged 76 to 85.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Oncology

COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

Aakash Desai et al.

Summary: The rapid development of COVID-19 vaccines has provided new hope of mitigating the disease, and it is necessary to prioritize cancer patients, including those participating in oncology clinical trials, for vaccination. Data on the safety, tolerability and efficacy of the vaccines in patients with cancer are currently limited, but the benefits of vaccination are likely to far outweigh the risks of adverse events.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Surgery

DElayed COloRectal cancer care during COVID-19 Pandemic (DECOR-19): Global perspective from an international survey

Giulio A. Santoro et al.

Summary: A survey on colorectal cancer care during the COVID-19 pandemic analyzed the global impact of the virus. Changes in colorectal cancer care were associated with differences in healthcare delivery systems, hospital preparedness, resource availability, and local COVID-19 prevalence rather than geographic factors. Strategic planning is needed to optimize colorectal cancer care in the face of a pandemic.

SURGERY (2021)

Review Oncology

Telehealth for Cancer Care in Veterans: Opportunities and Challenges Revealed by COVID

Cindy Y. Jiang et al.

Summary: The Veterans Health Administration system is utilizing telehealth to provide more convenient cancer care services to veterans. There are opportunities and challenges in using telehealth for cancer care, and optimization of its role in the healthcare system can be achieved through evaluation and integration of lessons learned.

JCO ONCOLOGY PRACTICE (2021)

Article Cell Biology

Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency

Kazuhito Honjo et al.

Summary: Convalescent plasma (CP) has beneficial effects in severely ill COVID-19 patients, even when administered relatively late in the disease course. However, there are widely varying neutralizing antibody (NAbs) titers within different CP units, highlighting the importance of determining neutralizing activity for maximizing therapeutic benefits.

CELL REPORTS MEDICINE (2021)

Review Gastroenterology & Hepatology

Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies

John M. Carethers et al.

GASTROENTEROLOGY (2020)

Article Oncology

Colorectal cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Article Medicine, General & Internal

Clinical Characteristics of Coronavirus Disease 2019 in China

W. Guan et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Gastroenterology & Hepatology

Caring for Patients with Rectal Cancer During the COVID-19 Pandemic

Kinga B. Skowron et al.

JOURNAL OF GASTROINTESTINAL SURGERY (2020)

Article Medicine, General & Internal

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

Nicole M. Kuderer et al.

LANCET (2020)

Article Public, Environmental & Occupational Health

High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice - Skagit County, Washington, March 2020

Lea Hamner et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)

Article Medicine, General & Internal

Remdesivir for the Treatment of Covid-19-Final Report

John H. Beigel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Editorial Material Gastroenterology & Hepatology

The Impact of the Coronavirus Disease-19 Pandemic on Access to Endoscopy Procedures in the VA Healthcare System COMMENT

Andrew J. Gawron et al.

GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Impact of COVID-19 on colorectal cancer disparities and the way forward

Sophie Balzora et al.

GASTROINTESTINAL ENDOSCOPY (2020)

Article Oncology

Hematology and oncology clinical care during the coronavirus disease 2019 pandemic

Manish A. Shah et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Letter Infectious Diseases

Viral dynamics in mild and severe cases of COVID-19

Yang Liu et al.

LANCET INFECTIOUS DISEASES (2020)

Editorial Material Multidisciplinary Sciences

COVID-19 and cancer

Norman E. Sharpless

SCIENCE (2020)

Article Oncology

COVID-19 Severity and Outcomes in Patients With Cancer: A Matched Cohort Study

Gagandeep Brar et al.

JOURNAL OF CLINICAL ONCOLOGY (2020)

Review Medicine, General & Internal

Household Transmission of SARS-CoV-2 A Systematic Review and Meta-analysis

Zachary J. Madewell et al.

JAMA NETWORK OPEN (2020)

Article Medicine, General & Internal

Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19

Ning Rosenthal et al.

JAMA NETWORK OPEN (2020)

Article Immunology

Transmission of SARS-CoV-2 During Long-Haul Flight

Nguyen Cong Khanh et al.

EMERGING INFECTIOUS DISEASES (2020)

Letter Immunology

COVID-19 Outbreak Associated with Air Conditioning in Restaurant, Guangzhou, China, 2020

Jianyun Lu et al.

EMERGING INFECTIOUS DISEASES (2020)

Review Gastroenterology & Hepatology

Risk of COVID-19 Transmission During Gastrointestinal Endoscopy

Surinder Sing Rana

JOURNAL OF DIGESTIVE ENDOSCOPY (2020)

Article Oncology

Colorectal Cancer Screening for Average-Risk Adults: 2018 Guideline Update From the American Cancer Society

Andrew M. D. Wolf et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2018)

Review Oncology

Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma

Joseph Kannarkatt et al.

JOURNAL OF ONCOLOGY PRACTICE (2017)

Review Gastroenterology & Hepatology

Colonoscopy Reduces Colorectal Cancer Incidence and Mortality in Patients With Non-Malignant Findings: A Meta-Analysis

Jun Pan et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

Consequences of Increasing Time to Colonoscopy Examination After Positive Result From Fecal Colorectal Cancer Screening Test

Reinier G. S. Meester et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Gastroenterology & Hepatology

Racial Minorities Are More Likely Than Whites to Report Lack of Provider Recommendation for Colon Cancer Screening

Folasade P. May et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)

Letter Oncology

Maintenance treatment in metastatic colorectal cancer

Lieke H. J. Simkens et al.

LANCET ONCOLOGY (2015)

Article Medicine, General & Internal

Randomized Trial of TAS-102 for Refractory Metastatic Colorectal Cancer

Robert J. Mayer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Review Biotechnology & Applied Microbiology

Practical review of immunizations in adult patients with cancer

Ella J. Ariza-Heredia et al.

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2015)

Article Immunology

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

Lorry G. Rubin et al.

CLINICAL INFECTIOUS DISEASES (2014)

Article Gastroenterology & Hepatology

Should capecitabine replace 5-fluorouracil in the first-line treatment of metastatic colorectal cancer?

Carlos Aguado et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2014)